{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T19:49:29Z","timestamp":1774122569718,"version":"3.50.1"},"reference-count":49,"publisher":"Elsevier BV","issue":"48","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.vaccine.2010.09.041","type":"journal-article","created":{"date-parts":[[2010,9,26]],"date-time":"2010-09-26T09:43:53Z","timestamp":1285494233000},"page":"7652-7658","source":"Crossref","is-referenced-by-count":41,"title":["Immunogenicity of a protective whole cell mycobacterial vaccine in HIV-infected adults: A phase III study in Tanzania"],"prefix":"10.1016","volume":"28","author":[{"given":"Timothy","family":"Lahey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert D.","family":"Arbeit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Bakari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. Robert","family":"Horsburgh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mecky","family":"Matee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Waddell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lillian","family":"Mtei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenni M.","family":"Vuola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kisali","family":"Pallangyo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. Fordham","family":"von Reyn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2010.09.041_bib0005","first-page":"255","article-title":"Protective vaccination against tuberculosis with special reference to BCG vaccination","volume":"58","author":"Aronson","year":"1948","journal-title":"Am Rev Tuberc"},{"key":"10.1016\/j.vaccine.2010.09.041_bib0010","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0041-3879(49)80055-9","article-title":"BCG vaccination of infant Indians in Saskatchewan","volume":"30","author":"Ferguson","year":"1949","journal-title":"Tubercle"},{"key":"10.1016\/j.vaccine.2010.09.041_bib0015","first-page":"690","article-title":"BCG vaccination in tuberculous households","volume":"84","author":"Rosenthal","year":"1960","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.vaccine.2010.09.041_bib0020","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1542\/peds.28.4.622","article-title":"BCG vaccination against tuberculosis in Chicago: a twenty year study statistically analyzed","volume":"28","author":"Rosenthal","year":"1961","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2010.09.041_bib0025","first-page":"517","article-title":"Results of BCG immunization in New York City","volume":"53","author":"Levine","year":"1948","journal-title":"Am Rev Tuberc"},{"key":"10.1016\/j.vaccine.2010.09.041_bib0030","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1542\/peds.96.1.29","article-title":"The efficacy of bacillus Calmette-Gu\u00e9rin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature","volume":"96","author":"Colditz","year":"1995","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2010.09.041_bib0035","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.271.9.698","article-title":"Efficacy of BCG vaccine in the prevention of tuberculosis: meta-analysis of the published literature","volume":"271","author":"Colditz","year":"1994","journal-title":"JAMA"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2010.09.041_bib0040","first-page":"200","article-title":"Does the efficacy of BCG decline with time since vaccination?","volume":"2","author":"Sterne","year":"1998","journal-title":"Int J Tuberc Lung Dis"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2010.09.041_bib0045","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1136\/adc.64.4.634","article-title":"Duration of protection against tuberculosis conferred by BCG vaccination in infancy","volume":"64","author":"Packe","year":"1989","journal-title":"Arch Dis Child"},{"issue":"May 5 (17)","key":"10.1016\/j.vaccine.2010.09.041_bib0050","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1001\/jama.291.17.2086","article-title":"Long-term efficacy of BCG vaccine in American Indians and Alaska Natives: a 60-year follow-up study","volume":"291","author":"Aronson","year":"2004","journal-title":"Jama"},{"key":"10.1016\/j.vaccine.2010.09.041_bib0055","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0140-6736(96)02166-6","article-title":"Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi","volume":"348","year":"1996","journal-title":"Lancet"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2010.09.041_bib0060","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nrmicro1419","article-title":"Advances in tuberculosis vaccine strategies","volume":"4","author":"Skeiky","year":"2006","journal-title":"Nat Rev Microbiol"},{"issue":"July 12 (9633)","key":"10.1016\/j.vaccine.2010.09.041_bib0065","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0140-6736(08)61036-3","article-title":"Tuberculosis vaccine development: goals, immunological design, and evaluation","volume":"372","author":"Hoft","year":"2008","journal-title":"Lancet"},{"issue":"August 15 (4)","key":"10.1016\/j.vaccine.2010.09.041_bib0070","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1086\/341901","article-title":"New vaccines for the prevention of tuberculosis","volume":"35","author":"von Reyn","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"May 3 (7)","key":"10.1016\/j.vaccine.2010.09.041_bib0075","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1097\/00002030-200205030-00013","article-title":"Community study of the relative impact of HIV-1 and HIV-2 on intrathoracic tuberculosis","volume":"16","author":"Seng","year":"2002","journal-title":"Aids"},{"key":"10.1016\/j.vaccine.2010.09.041_bib0080","series-title":"Global Tuberculosis Control: Surveillance, Planning, Financing","author":"WHO","year":"2008"},{"issue":"March 18 (9514)","key":"10.1016\/j.vaccine.2010.09.041_bib0085","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/S0140-6736(06)68384-0","article-title":"Global epidemiology of tuberculosis","volume":"367","author":"Dye","year":"2006","journal-title":"Lancet"},{"issue":"February 4 (5)","key":"10.1016\/j.vaccine.2010.09.041_bib0090","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1056\/NEJM199902043400507","article-title":"Tuberculosis in patients with human immunodeficiency virus infection","volume":"340","author":"Havlir","year":"1999","journal-title":"N Engl J Med"},{"issue":"(June) Suppl. 3","key":"10.1016\/j.vaccine.2010.09.041_bib0095","doi-asserted-by":"crossref","first-page":"S309","DOI":"10.1086\/313880","article-title":"Safety and immunogenicity of a five-dose series of inactivated Mycobacterium vaccae vaccination for the prevention of HIV-associated tuberculosis","volume":"30","author":"Waddell","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"November 7 (16)","key":"10.1016\/j.vaccine.2010.09.041_bib0100","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1097\/00002030-200311070-00010","article-title":"Immunogenicity of an inactivated mycobacterial vaccine for the prevention of HIV-associated tuberculosis: a randomized, controlled trial","volume":"17","author":"Vuola","year":"2003","journal-title":"Aids"},{"issue":"January 28 (24(5))","key":"10.1016\/j.vaccine.2010.09.041_bib0105","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/QAD.0b013e3283350f1b","article-title":"Prevention of tuberculosis in Bacille Calmette-Guerin-primed. HIV-infected adults boosted with an inactivated whole-cell mycobacterial vaccine","volume":"13","author":"von Reyn","year":"2010","journal-title":"Aids"},{"issue":"January\u2013February (1\u20132)","key":"10.1016\/j.vaccine.2010.09.041_bib0110","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0300-9084(03)00048-8","article-title":"Lipoarabinomannans: from structure to biosynthesis","volume":"85","author":"Nigou","year":"2003","journal-title":"Biochimie"},{"key":"10.1016\/j.vaccine.2010.09.041_bib0115","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1471-2334-9-21","article-title":"Lymphocyte proliferation to mycobacterial antigens is detectable across a spectrum of HIV-associated tuberculosis","volume":"9","author":"Lahey","year":"2009","journal-title":"BMC Infect Dis"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2010.09.041_bib0120","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0264-410X(96)00057-6","article-title":"Immunogenicity of influenza vaccine (1993\u201394 winter season) in HIV-seropositive and -seronegative ex-intravenous drug users","volume":"15","author":"Iorio","year":"1997","journal-title":"Vaccine"},{"issue":"April 22 (22)","key":"10.1016\/j.vaccine.2010.09.041_bib0125","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1016\/j.vaccine.2004.11.057","article-title":"Randomized trial of recombinant hepatitis B vaccine in HIV-infected adult patients comparing a standard dose to a double dose","volume":"23","author":"Fonseca","year":"2005","journal-title":"Vaccine"},{"issue":"April 1 (7)","key":"10.1016\/j.vaccine.2010.09.041_bib0130","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1086\/597304","article-title":"HIV-1 infection in infants severely impairs the immune response induced by Bacille Calmette-Guerin vaccine","volume":"199","author":"Mansoor","year":"2009","journal-title":"J Infect Dis"},{"issue":"February (3)","key":"10.1016\/j.vaccine.2010.09.041_bib0135","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1128\/JVI.78.3.1160-1168.2004","article-title":"T-cell subsets that harbor human immunodeficiency virus (HIV) in vivo: implications for HIV pathogenesis","volume":"78","author":"Brenchley","year":"2004","journal-title":"J Virol"},{"issue":"May 2 (6884)","key":"10.1016\/j.vaccine.2010.09.041_bib0140","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/417095a","article-title":"HIV preferentially infects HIV-specific CD4+ T cells","volume":"417","author":"Douek","year":"2002","journal-title":"Nature"},{"issue":"December 1 (11)","key":"10.1016\/j.vaccine.2010.09.041_bib0145","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1086\/593017","article-title":"Early depletion of Mycobacterium tuberculosis-specific T helper 1 cell responses after HIV-1 infection","volume":"198","author":"Geldmacher","year":"2008","journal-title":"J Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2010.09.041_bib0250","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1086\/656332","article-title":"Interferon \u03b3 responses to mycobacterial antigens protect against subsequent HIV-associated tuberculosis","volume":"202","author":"Lahey","year":"2010","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2010.09.041_bib0255","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/QAD.0b013e3283350f1b","article-title":"Prevention of tuberculosis in Bacille Calmette-Gu\u00e9rin-primed, HIV-infected adults boosted with an inactivated whole-cell mycobacterial vaccine","volume":"24","author":"von Reyn","year":"2010","journal-title":"AIDS"},{"issue":"March 1 (5)","key":"10.1016\/j.vaccine.2010.09.041_bib0160","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1086\/381763","article-title":"Counting antigen-specific T cells: a new approach for monitoring response to tuberculosis treatment?","volume":"38","author":"Lalvani","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"March 1 (5)","key":"10.1016\/j.vaccine.2010.09.041_bib0165","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1086\/381754","article-title":"Use of a T cell-based assay for monitoring efficacy of antituberculosis therapy","volume":"38","author":"Carrara","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"July 1 (7)","key":"10.1016\/j.vaccine.2010.09.041_bib0170","doi-asserted-by":"crossref","first-page":"e145","DOI":"10.1371\/journal.pmed.0050145","article-title":"Immunological outcomes of new tuberculosis vaccine trials: WHO panel recommendations","volume":"5","author":"Hanekom","year":"2008","journal-title":"PLoS Med"},{"issue":"November (6)","key":"10.1016\/j.vaccine.2010.09.041_bib0175","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.tube.2008.06.005","article-title":"A comparison of IFNgamma detection methods used in tuberculosis vaccine trials","volume":"88","author":"Beveridge","year":"2008","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/j.vaccine.2010.09.041_bib0180","doi-asserted-by":"crossref","unstructured":"Kagina BM, Abel B, Scriba TJ, Hughes EJ, Keyser A, Soares A, et al. Specific T cell frequency and cytokine expression profile do not correlate with protection against tuberculosis, following BCG vaccination of newborns. Am J Respir Crit Care Med 2010 Jun 17. [Epub ahead of print].","DOI":"10.1164\/rccm.201003-0334OC"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2010.09.041_bib0185","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1128\/IAI.65.5.1856-1862.1997","article-title":"Induction of a type 1 immune response to a recombinant antigen from Mycobacterium tuberculosis expressed in Mycobacterium vaccae","volume":"65","author":"Abou-Zeid","year":"1997","journal-title":"Infect Immun"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2010.09.041_bib0190","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1046\/j.1365-2567.1998.00432.x","article-title":"Inhibition of an established allergic response to ovalbumin in BALB\/c mice by killed Mycobacterium vaccae","volume":"93","author":"Wang","year":"1998","journal-title":"Immunology"},{"issue":"December (6)","key":"10.1016\/j.vaccine.2010.09.041_bib0195","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1164\/ajrccm.162.6.9909087","article-title":"Effects of specific immunotherapy in allergic rhinitic individuals with bronchial hyperresponsiveness","volume":"162","author":"Grembiale","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2010.09.041_bib0200","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1128\/IAI.65.8.3317-3327.1997","article-title":"Pathogenesis of tuberculosis in mice exposed to low and high doses of an environmental mycobacterial saprophyte before infection","volume":"65","author":"Hernandez-Pando","year":"1997","journal-title":"Infect Immun"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2010.09.041_bib0205","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1046\/j.1365-2567.2001.01207.x","article-title":"Analysis of recombinant mycobacteria as T helper type 1 vaccines in an allergy challenge model","volume":"102","author":"Janssen","year":"2001","journal-title":"Immunology"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2010.09.041_bib0210","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1183\/09031936.03.00042103","article-title":"The effects of Mycobacterium vaccae on allergen-induced airway responses in atopic asthma","volume":"21","author":"Camporota","year":"2003","journal-title":"Eur Respir J"},{"issue":"November 15 (10)","key":"10.1016\/j.vaccine.2010.09.041_bib0215","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1086\/592450","article-title":"A new recombinant bacille Calmette-Guerin vaccine safely induces significantly enhanced tuberculosis-specific immunity in human volunteers","volume":"198","author":"Hoft","year":"2008","journal-title":"J Infect Dis"},{"issue":"July (4)","key":"10.1016\/j.vaccine.2010.09.041_bib0220","first-page":"901","article-title":"Bactericidal activity in whole blood as a potential surrogate marker of immunity after vaccination against tuberculosis","volume":"9","author":"Cheon","year":"2002","journal-title":"Clin Diagn Lab Immunol"},{"issue":"9729","key":"10.1016\/j.vaccine.2010.09.041_bib0260","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1016\/S0140-6736(10)60359-5","article-title":"Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice","volume":"375","author":"Wallis","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2010.09.041_bib0230","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1749-6632.1968.tb16704.x","article-title":"Identification of the tuberculous-infected by skin tests","volume":"154","author":"Edwards","year":"1968","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.vaccine.2010.09.041_bib0235","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0140-6736(95)92348-9","article-title":"Variation in protection by BCG: implications of and for heterologous immunity","volume":"346","author":"Fine","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2010.09.041_bib0240","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1093\/infdis\/145.2.733","article-title":"Infection with Mycobacterium avium-intracellulare and the protective effects of Bacille Calmette-Guerin","volume":"145","author":"Edwards","year":"1982","journal-title":"J Infect Dis"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2010.09.041_bib0245","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1128\/IAI.73.4.2190-2196.2005","article-title":"Differential effects of prior exposure to environmental mycobacteria on vaccination with Mycobacterium bovis BCG or a recombinant BCG strain expressing RD1 antigens","volume":"73","author":"Demangel","year":"2005","journal-title":"Infect Immun"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10013514?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10013514?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,3]],"date-time":"2023-06-03T13:56:18Z","timestamp":1685800578000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X10013514"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":49,"journal-issue":{"issue":"48","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S0264410X10013514"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.09.041","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}